Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
News
- iScience: Predicting and interpreting protein and phosphoprotein abundance from pan-cancer and single-cell transcriptomes (Chen Lab)
- Nature Communications: Cryo-EM structures of UBA6 reveal mechanisms of E1–E2 specificity and dual FAT10/ubiquitin thioester transfer (Olsen, Wasmuth, Sung,)
- Congratulations to Elizabeth Wasmuth, PhD on Her UT Health SA Presidential Excellence Award
- Chemical Science: Unveiling BCL-xL-specific PROTAC efficiency and dissociation pathways using native mass spectrometry (Olsen, Zhou)
- KABB TV (Fox SA) and WOAI-TV (NEWS4SA): Road to Gold — International Childhood Cancer Day celebrates perseverance of young patients
Events
Greehey CCRI Spring Seminar Series: Min Kyu Kim, PhD, MS (UTHSA)
Presentation title: “Regulation of BRCA-1 Phosphorylation in Genome Repair.”
Greehey CCRI Spring Seminar Series: Uttiya Basu, PhD (Columbia)
Presentation title: Somatic Hypermutation Mechanisms in B-Cell Immunity and Cancer
Greehey CCRI Spring Seminar Series: James Haber, PhD (Brandeis Univ)
Presentation title: “Fidelity and infidelity in repairing broken chromosomes”
